Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

October 17, 2014 – The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and ...

Home October 17, 2014
Home
News

October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

As of ...

Home October 15, 2014
Home
News

October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage ...

Home October 13, 2014
Home
Technology

September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients ...

Home September 29, 2014
Home
Feature

September 26, 2014 — The American Association for Thoracic Surgery (AATS) has released new evidence-based guidelines for ...

Home September 26, 2014
Home
Technology

September 26, 2014 — AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible ...

Home September 26, 2014
Home
News

September 15, 2014 — A new gene-directed drug being tested through a research study called GENETIC-AF may improve care ...

Home September 15, 2014
Home
News

September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein ...

Home September 02, 2014
Home
News
September 2, 2014 – Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare ...
Home September 02, 2014
Home
News

September 2, 2014 – John Muir Health's Concord medical center is the first hospital in Northern California and one of ...

Home September 02, 2014
Home
Technology

August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for ...

Home August 22, 2014
Home
News

August 18, 2014 — A clinical trial being conducted at Mission Health using Medtronic's Phased Radiofrequency (RF) ...

Home August 18, 2014
Home
News

August 14, 2014 — New data from the Medtronic Inc. Adaptive CRT trial show a 61 percent (p=0.01) lower risk of atrial ...

Home August 14, 2014
Home
News

July 30, 2014 — St. Jude Medical announced CE mark approval and first use of the FlexAbility ablation catheter, a novel ...

Home July 30, 2014
Home
Videos | Atrial Fibrillation

Paul Keall, Ph.D., FAAP, professor and NHMRC Australian Fellow at Radiation Physics Laboratory at the University of ...

Home July 30, 2014
Home
Subscribe Now